Business
The Impedimed (ASX:IPD) share price rocketed 13% today. Here’s why
The Impedimed Limited (ASX: IPD) share price was off to a flying start this morning, up 13% at market open.
The positive price movement came as the medical technology company announced it received Food and Drug Administration (FDA) clearance for a new heart monitoring device in the United States.
At the time of writing, shares in the company are up 8.7%, trading at 12.5 cents. By comparison, the S&P/ASX All Ordinaries Index (ASX: XAO) is 0.08% higher.
Let’s take a closer look at today’s news and what it means for the Impedimed share price.
Impedimed’s new product
In a statement to the ASX, Impedimed advised it has received FDA…
-
General21 hours agoMigrants raise concerns over Australia’s English tests for visa applicants
-
Noosa News23 hours agoSunshine Coast women celebrated at 26th annual business awards
-
Noosa News15 hours agoThe only person detained at Brisbane’s Palestine rally
-
Noosa News24 hours agoNew FLC President has regional lens – Proctor